
Attana Investor Relations Material
Latest events

Q2 2025
21 Aug, 2025

Q1 2025
9 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Attana
Access all reports
Attana AB is a Sweden-based biotechnology company specializing in real-time molecular interaction analysis. The company develops biosensors and analytical systems designed to simulate in vivo conditions, enabling the study of interactions between biomolecules such as proteins, antibodies, and cells. Attana’s solutions are utilized in drug development, diagnostics, and life sciences research. The company is headquartered in Stockholm, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ATANA
Country
🇸🇪 Sweden